The Raft of New 0.01% Atropine Studies: What They Tell Us for Practice
Provider: Mivision
Activity Outline
Published research on the intervention of myopia progression has been increasing at a remarkable rate. However, how we interpret this research into clinical practice remains challenging. Recent publications on atropine 0.01% have reported varying results and conclusions, highlighting questions and interpretations in clinical practice. This article aims to analyse these studies to aid best management of myopia progression in children.
Learning Objectives
- Better understand the current literature on using atropine drops for myopia intervention
- Better understand comparisons for various results using atropine drops
- Interpret the relevance of myopia intervention in clinical practice
- Incorporate new studies into clinical practice
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| The Raft of New 0.01% Atropine Studies: What They Tell Us for Practice |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |